298 related articles for article (PubMed ID: 21416002)
1. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.
Takacs M; Segesdi J; Banati F; Koroknai A; Wolf H; Niller HH; Minarovits J
Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009012. PubMed ID: 21416002
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
3. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.
Li H; Minarovits J
Adv Cancer Res; 2003; 89():133-56. PubMed ID: 14587872
[TBL] [Abstract][Full Text] [Related]
4. Epigenotypes of latent herpesvirus genomes.
Minarovits J
Curr Top Microbiol Immunol; 2006; 310():61-80. PubMed ID: 16909907
[TBL] [Abstract][Full Text] [Related]
5. The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program.
Murray-Nerger LA; Maestri D; Liu X; Li Z; Tempera I; Teng M; Gewurz BE
bioRxiv; 2024 May; ():. PubMed ID: 38766209
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
8. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
9. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
10. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.
Oudejans JJ; van den Brule AJ; Jiwa NM; de Bruin PC; Ossenkoppele GJ; van der Valk P; Walboomers JM; Meijer CJ
Blood; 1995 Sep; 86(5):1893-902. PubMed ID: 7655018
[TBL] [Abstract][Full Text] [Related]
11. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.
Chau CM; Lieberman PM
J Virol; 2004 Nov; 78(22):12308-19. PubMed ID: 15507618
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.
Owen TJ; O'Neil JD; Dawson CW; Hu C; Chen X; Yao Y; Wood VH; Mitchell LE; White RJ; Young LS; Arrand JR
Mol Cancer; 2010 Sep; 9():241. PubMed ID: 20843307
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
Brooks L; Yao QY; Rickinson AB; Young LS
J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
[TBL] [Abstract][Full Text] [Related]
14. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-host cell interactions: an epigenetic dialog?
Niller HH; Szenthe K; Minarovits J
Front Genet; 2014; 5():367. PubMed ID: 25400657
[TBL] [Abstract][Full Text] [Related]
18. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
19. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
20. Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression.
Yifei L; Jinjie Y; Beri NR; Roth LG; Ethel C; Benjamin E G
bioRxiv; 2024 Jan; ():. PubMed ID: 38260430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
